This map shows the geographic impact of J.A. Schalken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.A. Schalken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.A. Schalken more than expected).
This network shows the impact of papers produced by J.A. Schalken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.A. Schalken. The network helps show where J.A. Schalken may publish in the future.
Co-authorship network of co-authors of J.A. Schalken
This figure shows the co-authorship network connecting the top 25 collaborators of J.A. Schalken.
A scholar is included among the top collaborators of J.A. Schalken based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with J.A. Schalken. J.A. Schalken is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Dijk, Boukje A. C. van, Leo J. Schouten, Christina A. Hulsbergen‐van de Kaa, et al.. (2002). Risk factors, genetic predisposition and mutations in the VHL gene in sporadic renal cell carcinoma: The Netherlands Cohort Study.. PubMed. 156. 509–10.1 indexed citations
Smedts, Frank, et al.. (1998). Identification of intermediate cell types by keratin expression in the developing human prostate. (vol 34, pg 292, 1998). The Prostate. 35(2).4 indexed citations
8.
Xue, Yan, et al.. (1998). Tenascin-C expression in prostatic intraepithelial neoplasia (PIN): a marker of progression?. PubMed. 18(4A). 2679–84.22 indexed citations
Shimazui, Toru, Egbert Oosterwijk, Hideyuki Akaza, et al.. (1998). Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients with E-cadherin-absent renal cell carcinoma.. PubMed. 4(10). 2419–24.27 indexed citations
11.
Poel, H.G. Van Der, M. E. Boon, E. C. M. Ooms, et al.. (1997). Conventional bladder wash cytology performed by four experts versus quantitative image analysis.. PubMed. 10(10). 976–82.18 indexed citations
12.
Oosterwijk, Egbert, F.M.J. Debruyne, & J.A. Schalken. (1995). The use of monoclonal antibody G250 in the therapy of renal-cell carcinoma.. PubMed. 22(1). 34–41.31 indexed citations
13.
Peelen, W. P., et al.. (1992). Establishment and characterization of five new human renal tumor xenografts.. PubMed. 140(2). 483–95.20 indexed citations
14.
Karthaus, Herbert F.M., Wouter F.J. Feitz, J.A. Schalken, et al.. (1992). Multidisciplinary evaluation of rat renal cell carcinoma.. PubMed. 1(6). 335–41.2 indexed citations
15.
Schaafsma, H. Ewout, F. C. S. Ramaekers, H Robben, et al.. (1991). Cytokeratin expression patterns in metastatic transitional cell carcinoma of the urinary tract. An immunohistochemical study comparing local tumor and autologous metastases.. PubMed. 139(6). 1389–400.31 indexed citations
Roebroek, Anton, Gerard J.M. Martens, Ashley J. Duits, et al.. (1989). Differential expression of the gene encoding the novel pituitary polypeptide 7B2 in human lung cancer cells.. PubMed. 49(15). 4154–8.19 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.